Early Morning Insomnia with Rapidly Eliminated Benzodiazepines
The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Abstract
Early morning insomnia, a significant increase in wakefulness during the final hours of drug nights, occurred after 1 or 2 weeks of nightly administration of benzodiazepine hypnotics with short elimination half-lives, when tolerance had begun to develop. Early morning insomnia may be a variant of rebound insomnia and therefore specific to benzodiazepines, or it may occur with any rapidly eliminated sedative-hypnotic agent.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, early-morning insomnia associated with short-acting benzodiazepines triazolam and midazolam markedly worsened after 7 days of treatment [43].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [43]
In the citing paper
“Other new withdrawal symptoms that may be more specific to a certain class of CNS drugs include lacrimation, rhinorrhea, and sneezing for opiates, paroxysmal sweats for alcohol, and increased appetite for nicotine [10,23,24] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [23]
In the citing paper
“Rebound with short-acting drugs may be best illustrated by withdrawal from cocaine and heroin, which both have a rapid onset and brief duration of action [10,23] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [23]
In the citing paper
“Persistent postwithdrawal disorders have been described with different classes of CNS drugs (e.g.protracted insomnia for alcohol and benzodiazepine withdrawal [10,36] and major depression/dysphoria for cocaine and amphetamine withdrawal [10,23] ), and even more so with specific drugs (e.g.quetiapine and paroxetine) within a drug class [6,15,16,33] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [23]
Citations
Cites
Multiple comparisons among means
Dunn, O. J. (1961) · Journal of the American Statistical Association · doi:10.1080/01621459.1961.10482090 · Cited by 5,006
Rebound Insomnia: A New Clinical Syndrome
Kales, A., Scharf, M. B., & Kales, J. D. (1978) · Science · doi:10.1126/science.684426 · Cited by 200
Self-citationRebound Insomnia and Rebound Anxiety: A Review
Kales, A., Soldatos, C. R., Bixler, E. O., & Kales, J. D. (2008) · Pharmacology · doi:10.1159/000137794 · Cited by 198
Self-citationKinetics and clinical effects of flurazepam in young and elderly noninsomniacs
Greenblatt, D. J., Divoll, M., Harmatz, J. S., MacLaughlin, D. S., & Shader, R. I. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.191 · Cited by 150
Anxiety caused by a short-life hypnotic.
Morgan, K., & Oswald, I. (1982) · BMJ · doi:10.1136/bmj.284.6320.942 · Cited by 137
Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines
Kales, A. (1979) · JAMA · doi:10.1001/jama.241.16.1692 · Cited by 136
Self-citationAlcohol and sleep in young adults
Rundell, O. H., Lester, B. K., Griffiths, W. J., & Williams, H. L. (1972) · Psychopharmacology · doi:10.1007/bf00422697 · Cited by 120
Blood Level Profile in Man following Chronic Oral Administration of Flurazepam Hydrochloride
Kaplan, S. A., de Silva, J. A. F., Jack, M. L., Alexander, K. M., Strojny, N., Weinfeld, R. E., Puglisi, C. V., & WEISSMAN, L. (1973) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600621205 · Cited by 103
Hypnotic Efficacy of Triazolam: Sleep Laboratory Evaluation of Intermediate‐Term Effectiveness
KALES, A., KALES, J. D., BIXLER, E. O., SCHARF, M. B., & RUSSEK, E. (1976) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1976.tb02414.x · Cited by 99
Self-citationHypnotic Drugs and Their Effectiveness: All-night EEG Studies of Insomniac Subjects
Kales, A. (1970) · Archives of General Psychiatry · doi:10.1001/archpsyc.1970.01750030034006 · Cited by 98
Self-citation
Research works printed but not linked: 3
- BRAESTRUP, C, BENZODIAZEPINE RECEPTORS, ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 30: 852 (1980).
- METZLER, C.M., BIOAVAILABILITY AND PHARMACOKINETICS OF ORALLY-ADMINISTERED TRIAZOLAM IN NORMAL SUBJECTS, CLINICAL PHARMACOLOGY & THERAPEUTICS 21: 111 (1977).
- Oswald, I., Pharmacology of the States of Alertness: 51 (1979).
Cited by
Items 101–138 of 138
Nutley, P. G. (1983) · BMJ · doi:10.1136/bmj.287.6387.290 · Cited by 2
Kubicki, S. (2002) · Springer eBooks · doi:10.1007/978-3-662-08106-8_5 · Cited by 2
Hypnotics and antihistamines : effects ono cognitive functions and driving performance
Vermeeren, A. (2003) · Research Publications (Maastricht University) · doi:10.26481/dis.20030509av · Cited by 2
Kales, A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107253250416 · Cited by 2
Self-citationRiedel, B. W., & Lichstein, K. L. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1456-9_18 · Cited by 2
Benzodiazepines for the treatment of sleep disorders
Pollak, C. P. (1990) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.57.s1.24 · Cited by 1
Brotizolam versus triazolam for the treatment of insomnia in anxious patients
Smirne, S., Cassano, G., Ferrillo, F., Maggini, C., Puca, F., Scarone, S., Terzano, M. G., & Moroni, M. (1993) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80149-3 · Cited by 1
Pharmacologic Information and the Doctor's Dilemma
BRESSLER, R. C. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.2.251 · Cited by 1
Schütz, H. F. (1988) · Vieweg+Teubner eBooks · doi:10.1007/978-3-663-20215-8_6 · Cited by 1
Kriterien für die Auswahl eines Schlafmittels
Oswald, I., & Adám, K. (1988) · Vieweg+Teubner eBooks · doi:10.1007/978-3-663-20215-8_5 · Cited by 1
Mechanisms of Benzodiazepine Drug Dependence
Vgontzas, A. N., & Kales, A. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_19 · Cited by 1
Self-citationEffect of Triazolam on Pilot Performance.
Caldwell, J. L., Caldwell, J. A., Sprenger, W. D., Woodrum, L. C., & Jones, H. D. (1996) · Cited by 2
Crismon, M. L. (1992) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-13175-4_55 · Cited by 1
Kales, A., Vgontzas, A. N., & Bixler, E. O. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_13 · Cited by 1
Self-citationKales, A. (1983) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1983.tb03241.x · Cited by 1
Self-citationHockings, N. (1983) · BMJ · doi:10.1136/bmj.287.6387.290-a · Cited by 1
Brunt, D. L. V., Riedel, B. W., & Lichstein, K. L. (1996) · Springer eBooks · doi:10.1007/978-1-4899-1528-3_14 · Cited by 1
Therapeutic focus: Management of insomnia
LADER, M. H. (1990) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1990.tb10758.x · Cited by 1
Sullivan, J. L., Sullivan, P. D., Mahorney, S., & Goldberg, R. L. (1984) · Elsevier eBooks · doi:10.1016/b978-0-409-95151-6.50008-0
Dr. Burgoyne and Associates Reply
Burgoyne, R. W., Acosta, F. X., & Yamamoto, J. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.1.138
Dr. Hudson and Associates Reply
Hudson, J. I., Hudson, M., Pliner, L. F., Goldenberg, D. L., & Pope, H. G. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.6.813
Berlin, R. M., & Conell, L. J. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.1.139
Policy Making in Administrative Psychiatry
Marcos, L. R., & Gil, M. J. C. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.1.139-a
Consultation-Liaison Psychiatry and Sleep Disorders
Berlin, R. M., Manfredi, R. L., & Noori, S. S. (1987) · Psychiatric Annals · doi:10.3928/0048-5713-19870701-12
Which is more dangerous—cycling or flying?
Forrester, J. (1983) · BMJ · doi:10.1136/bmj.287.6387.290-c
What Caused the Mania in Two Sisters?
KRASNOW, C. G. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.6.814-a
Integrated Image Associative Memory and Its Optical Implementation
Lee, J. S., Yamaguchi, M., & Ohyama, N. (1995) · Optical Review · doi:10.1007/s10043-995-0261-1
The Future of Anxiolytic Drug Therapy
Ayd, F. J. (1990) · International Review of Psychiatry · doi:10.3109/09540269009026608
Polysomnography and hypnotics.
KATORII, T. (1985) · The Annals of physiological anthropology · doi:10.2114/ahs1983.4.325
Pharmakotherapie von Schlafstörungen
Buchta, M., Höper, D. W., & Sönnichsen, A. C. (2004) · Springer-Lehrbuch · doi:10.1007/978-3-642-18569-4_195
The Psychiatric Subspecialty of Sleep Disorders Medicine
Kales, J. D., Manfredi, R. L., & Bixler, E. O. (1992) · Springer eBooks · doi:10.1007/978-1-4613-9194-4_27
Self-citationLemoine, P. (2004) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(02)00084-6
Bliwise, D. L. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.6.814
The family business: turning sleep into dreams
Kales, A., Kales, J. D., & Kales, H. C. (2023) · SLEEP Advances · doi:10.1093/sleepadvances/zpad036
Self-citationEdward O. Bixler, PhD: from the Apollo project and chimpanzees to sleep epidemiology
Fernández‐Mendoza, J., Calhoun, S. L., & Bixler, E. O. (2024) · SLEEP Advances · doi:10.1093/sleepadvances/zpae020
Self-citationSheehan, D. V. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as22
Benzodiazepines: half-life and daytime hyperarousal
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.6.aj1436813
Withdrawal symptoms after long-term treatment with flurazepam
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.1.aj1411138
Metadata
- Authors
- Kales, A., Soldatos, C. R., Bixler, E. O., & Kales, J. D.
- Affiliations
- Pennsylvania State University (US)
- Venue
- Science
- Published
- 1983-04
- Volume
- 220
- Issue
- 4592
- Pages
- 95-97
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1984857603
- Cited by
- 138
- References
- 18
- Citations by year
- 2024: 2 · 2023: 1 · 2019: 1 · 2015: 1 · 2012: 1
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Keywords
- benzodiazepines, rebound insomnia, benzodiazepine tolerance, sedative-hypnotic drugs
- MeSH terms
- Benzodiazepines, Flurazepam, Half-Life, Humans, Sleep Initiation and Maintenance Disorders, Midazolam, Sleep, Anti-Anxiety Agents, Triazolam
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.